文献速递心血管MR

肥厚型心肌病患者心肌纤维化的进展:一项心脏磁共振研究

Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-11-25

本研究纳入157例肥厚型心肌病患者,间隔4.7±1.9年行两次心脏磁共振检查,发现晚钆增强(LGE)比例从70%升至85%,LGE范围从4.0±5.6%增至6.3±7.4%,平均进展速率0.5±1.0%/年;LGE进展与未来植入植入式心律转复除颤器、射血分数恶化至≤50%及因心力衰竭入院显著相关。

要点

  • 肥厚型心肌病患者LGE阳性率从首次CMR的70%升至第二次的85%(p=0.001)。
  • LGE范围平均每年进展0.5±1.0%,基线LGE范围>8%、左室质量指数>100 g/m2、最大壁厚≥20 mm者进展更快。
  • LGE进展程度与未来植入ICD、EF恶化至≤50%及心力衰竭入院显著相关。

关键影像表现/征象

  • 首次CMR时70%患者存在LGE,第二次CMR时85%患者存在LGE(p=0.001)。
  • LGE范围从4.0±5.6%增加至6.3±7.4%(p<0.0001),平均LGE进展速率为0.5±1.0%/年。
  • LGE质量进展与首次CMR时较高的LGE质量和范围(分别为p=0.0017和p=0.007)、较大的左室质量指数(p<0.0001)、较大的左室最大壁厚(p<0.0001)、首次CMR时心尖部室壁瘤(p<0.0001)及较低的左室射血分数(p=0.029)相关。
  • 基线时LGE范围>8%、左室质量指数>100 g/m2、最大壁厚≥20 mm、左室射血分数≤60%及存在心尖部室壁瘤的患者更可能出现较高的LGE进展速率。

诊断标准与关键数值

  • LGE进展程度与未来植入植入式心律转复除颤器显著相关(p=0.004)。
  • LGE进展程度与射血分数恶化至≤50%显著相关(p<0.0001)。
  • LGE进展程度与因心力衰竭入院显著相关(p=0.0006)。

临床应用与阅片要点

  • 对于基线LGE范围>8%、左室质量指数>100 g/m2、最大壁厚≥20 mm、左室射血分数≤60%或存在心尖部室壁瘤的肥厚型心肌病患者,其LGE进展速率可能更高。
  • 作者认为,审慎使用系列CMR联合LGE检查可为患者管理提供有价值的信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study examined fibrosis progression in hypertrophic cardiomyopathy (HCM) patients, as well as its relationship to patient characteristics, clinical outcomes, and its effect on clinical decision making.

BACKGROUND: Myocardial fibrosis, as quantified by late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR), provides valuable prognostic information in patients with HCM.

METHODS: A total of 157 patients with HCM were enrolled in this study, with 2 sequential CMR scans separated by an interval of 4.7 ± 1.9 years.

RESULTS: At the first CMR session (CMR-1), 70% of patients had LGE compared with 85% at CMR-2 (p = 0.001). The extent of LGE extent increased between the 2 CMR procedures, from 4.0 ± 5.6% to 6.3 ± 7.4% (p < 0.0001), with an average LGE progression rate of 0.5 ± 1.0%/year. LGE mass progression was correlated with higher LGE mass and extent on CMR-1 (p = 0.0017 and p = 0.007, respectively), greater indexed left ventricular (LV) mass (p < 0.0001), greater LV maximal wall thickness (p < 0.0001), apical aneurysm at CMR-1 (p < 0.0001), and lower LV ejection fraction (EF) (p = 0.029). Patients who were more likely to have a higher rate of LGE progression presented with more severe disease at baseline, characterized by LGE extent >8% of LV mass, indexed LV mass >100 g/m2, maximal wall thickness ≥20 mm, LVEF ≤60%, and apical aneurysm. There was a significant correlation between the magnitude of LGE progression and future implantation of insertable cardioverter-defibrillators (p = 0.004), EF deterioration to ≤50% (p < 0.0001), and admission for heart failure (p = 0.0006).

CONCLUSIONS: Myocardial fibrosis in patients with HCM is a slowly progressive process. Progression of LGE is significantly correlated with a number of clinical outcomes such as progression to EF ≤50% and heart failure admission. Judicious use of serial CMR with LGE can provide valuable information to help patient management.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Habib M, Adler A, Fardfini K, et al. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study. JACC Cardiovasc Imaging. 2020. PMID: 33248971. doi:10.1016/j.jcmg.2020.09.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。